US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 1.860
  • 0.0000.00%
Close Feb 14 16:00 ET
  • 1.860
  • 0.0000.00%
Post 20:01 ET
57.75MMarket Cap-0.94P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Saint Jeremiah
    Saint Jeremiah
    Feb 12 13:36
    $Immuneering (IMRX.US)$I feel truly grateful to have had the opportunity to invest in Immuneering (IMRX) at such an early stage. I firmly believe in the potential of this company and the groundbreaking work they’re doing. The drugs they’re developing have the capacity to make a significant difference in the lives of so many people, and that’s something I deeply resonate with. The results they’ve achieved so far are nothing short of incredible, and it fills me with immense hope and gratitude. I tr...
    Picture
    1
    Saint Jeremiah
    Saint Jeremiah
    Feb 11 14:10
    $Immuneering (IMRX.US)$ IMRX is bursting with potential, a stock teeming with endless possibilities across multiple realities! No matter which path you envision, they all lead to the same thrilling destination—upward momentum. The only question is, how high will it go? Buckle up!
    Picture
    Saint Jeremiah
    Saint Jeremiah
    Feb 11 13:53
    $Immuneering (IMRX.US)$ $IMRX Immuneering isn’t just another biotech. They’re rewriting the rules of drug discovery using advanced bioinformatics, aiming to outsmart diseases at the molecular level. Their Deep Informatics Platform analyzes vast biological datasets to find hidden drug targets—essentially bringing AI-power
    🧬 A New Kind of Drug Design: Unlike traditional drugs that hit their targets constantly, Immuneering’s “Deep Cyclic Inhibition” strategy uses pulsed dosing to give cancer cells j...
    Saint Jeremiah
    Saint Jeremiah
    Feb 10 17:11
    $Immuneering (IMRX.US)$Yes, Immuneering Corporation is scheduled to present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025. The presentation will take place from 2:40 PM to 3:10 PM Eastern Time (11:40 AM to 12:10 PM Pacific Time) in Track 2. During this virtual event, CEO Ben Zeskind and Chief Scientific Officer Brett Hall will discuss the company’s pipeline, platform, and business strategy. The presentation will be webcast live and archived in the Investo...
    Saint Jeremiah
    Saint Jeremiah
    Feb 10 16:18
    $Immuneering (IMRX.US)$ Immuneering Corporation (NASDAQ: IMRX) has received varied price targets from analysts, reflecting optimism about its potential. Currently trading at $1.86 per share, targets range from $8.00 to $25.00, with an average of around $12.00, suggesting significant upside. Notably, Needham reaffirmed a $12.00 target, and Mizuho initiated coverage with a $10.00 target. These figures indicate potential growth, but the broad range highlights uncertainties typical of developmental b...
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+4.45%
Strategy
MSTR
+3.94%
Vale SA
VALE
+1.99%
KB Home
KBH
+1.28%
Apple
AAPL
+1.27%

Unlock the Full List